Germany· DE-A57-17d7a0f88963096b
Atracurium Hameln
A atracurium product containing atracurium besilate, registered in Germany by Hameln Pharma Gmbh. The same ATC class is registered in 13 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Atracurium is registered in 13 of 19 countries.
Countries holding a registration under ATC M03AC04 (atracurium), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 8 of them publish a price we can compare per daily dose
Atracurium · ATC M03AC04
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Atracurium Besilate
- Manufacturer
- Hameln Pharma Gmbh
- Country
- Germany (DE)
- ATC code
- M03AC04
- ATC class
- Atracurium
- Defined daily dose
- 38.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
60 interactions on record for atracurium.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Atracurium · interactions on record
60 records
- 12 severe
- 44 moderate
- 4 minor
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- ParomomycinA07AA06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Atracurium in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAtracurium BesylateHospira, Inc.
- FinlandAtracurium AbbottAbbott Scandinavia AB
- CzechiaATRACURIUM KALCEKSAS Kalceks, Riga
- IrelandAtracurium 10 mg/ml solution for injection/infusionHikma Farmacêutica (Portugal) S.A.
- BelgiumAtracurium Kalceks 10 mg/mlKalceks
- SwedenAtracurium Kalceks 10 mg/ml Injektions-/infusionsvätska, lösningAS KALCEKS
- NorwayTracriumAspen
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Belgium · Atracurium Kalceks, Tracrium
- Bulgaria · Атракуриум Калцекс, Тракриум
- Czechia · Atracurium Kalceks, Tracrium
- Estonia · Atracurium Besilate Kalceks, Atrakuuriumbesilaat Basi
- Spain · Besilato De Atracurio Hameln, Besilato De Atracurio Kalceks
- France · Atracurium Basi, Atracurium Hikma
- United Kingdom (Northern Ireland) · Atracurium Accord Healthcare, Atracurium Besilate Aspen Pharma Trading
- Hungary · Atracurium Besilate Kalceks, Tracrium
- Ireland · Atracurium Besilate Kalceks, Atracurium Hikma Farmacêutica (Portugal)
- Italy · Acurmil
- Lithuania · Atracurium Besilate Kalceks, Atrakurio Besilatas Basi
- Luxembourg · Tracrium
- Latvia · Atracurium Besilate Basi, Atracurium Besilate Kalceks
- Malta · Atracurium Kalceks
- Netherlands · Atracurium Hameln, Atracurium Kalceks
- Poland · Atracurium Kalceks, Tracrium
- Portugal · Besilato De Atracurio Basi, Besilato De Atracúrio Basi
- Romania · Atracurium Kalceks
- Sweden · Atracurium Hameln, Atracurium Kalceks
- Slovakia · Atracurium Kalceks
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/853d66e1-c75f-4556-ac4d-27051e0eef13 GET /v1/drugs/853d66e1-c75f-4556-ac4d-27051e0eef13?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Atracurium Besilate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about atracurium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.